BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 32331419)

  • 1. ERGO: Breaking Down the Wall between Human Health and Environmental Testing of Endocrine Disrupters.
    Holbech H; Matthiessen P; Hansen M; Schüürmann G; Knapen D; Reuver M; Flamant F; Sachs L; Kloas W; Hilscherova K; Leonard M; Arning J; Strauss V; Iguchi T; Baumann L
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
    Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
    Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative Strategy of Testing Systems for Identification of Endocrine Disruptors Inducing Metabolic Disorders-An Introduction to the OBERON Project.
    Audouze K; Sarigiannis D; Alonso-Magdalena P; Brochot C; Casas M; Vrijheid M; Babin PJ; Karakitsios S; Coumoul X; Barouki R
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening chemicals for thyroid-disrupting activity: A critical comparison of mammalian and amphibian models.
    Pickford DB
    Crit Rev Toxicol; 2010 Nov; 40(10):845-92. PubMed ID: 20684730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals.
    Murk AJ; Rijntjes E; Blaauboer BJ; Clewell R; Crofton KM; Dingemans MM; Furlow JD; Kavlock R; Köhrle J; Opitz R; Traas T; Visser TJ; Xia M; Gutleb AC
    Toxicol In Vitro; 2013 Jun; 27(4):1320-46. PubMed ID: 23453986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The EDCMET Project: Metabolic Effects of Endocrine Disruptors.
    Küblbeck J; Vuorio T; Niskanen J; Fortino V; Braeuning A; Abass K; Rautio A; Hakkola J; Honkakoski P; Levonen AL
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32344727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecological risk assessment of endocrine disruptors.
    Hutchinson TH; Brown R; Brugger KE; Campbell PM; Holt M; Länge R; McCahon P; Tattersfield LJ; van Egmond R
    Environ Health Perspect; 2000 Nov; 108(11):1007-14. PubMed ID: 11102288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the scientific underpinnings for identifying estrogenic chemicals in nonmammalian taxa using mammalian test systems.
    Ankley GT; LaLone CA; Gray LE; Villeneuve DL; Hornung MW
    Environ Toxicol Chem; 2016 Nov; 35(11):2806-2816. PubMed ID: 27074246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OECD approaches and considerations for regulatory evaluation of endocrine disruptors.
    Browne P; Van Der Wal L; Gourmelon A
    Mol Cell Endocrinol; 2020 Mar; 504():110675. PubMed ID: 31830512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current limitations and recommendations to improve testing for the environmental assessment of endocrine active substances.
    Coady KK; Biever RC; Denslow ND; Gross M; Guiney PD; Holbech H; Karouna-Renier NK; Katsiadaki I; Krueger H; Levine SL; Maack G; Williams M; Wolf JC; Ankley GT
    Integr Environ Assess Manag; 2017 Mar; 13(2):302-316. PubMed ID: 27791330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Review of Read-Across Potential in Testing for Endocrine-Related Effects in Vertebrate Ecological Receptors.
    McArdle ME; Freeman EL; Staveley JP; Ortego LS; Coady KK; Weltje L; Weyers A; Wheeler JR; Bone AJ
    Environ Toxicol Chem; 2020 Apr; 39(4):739-753. PubMed ID: 32030793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ENDpoiNTs Project: Novel Testing Strategies for Endocrine Disruptors Linked to Developmental Neurotoxicity.
    Lupu D; Andersson P; Bornehag CG; Demeneix B; Fritsche E; Gennings C; Lichtensteiger W; Leist M; Leonards PEG; Ponsonby AL; Scholze M; Testa G; Tresguerres JAF; Westerink RHS; Zalc B; Rüegg J
    Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of in vivo assays for endocrine disruption.
    Clode SA
    Best Pract Res Clin Endocrinol Metab; 2006 Mar; 20(1):35-43. PubMed ID: 16522518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-species conservation of endocrine pathways: a critical analysis of tier 1 fish and rat screening assays with 12 model chemicals.
    Ankley GT; Gray LE
    Environ Toxicol Chem; 2013 Apr; 32(5):1084-7. PubMed ID: 23401061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The OECD validation program of the H295R steroidogenesis assay: Phase 3. Final inter-laboratory validation study.
    Hecker M; Hollert H; Cooper R; Vinggaard AM; Akahori Y; Murphy M; Nellemann C; Higley E; Newsted J; Laskey J; Buckalew A; Grund S; Maletz S; Giesy J; Timm G
    Environ Sci Pollut Res Int; 2011 Mar; 18(3):503-15. PubMed ID: 20890769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Approach Methodologies for the Endocrine Activity Toolbox: Environmental Assessment for Fish and Amphibians.
    Mitchell CA; Burden N; Bonnell M; Hecker M; Hutchinson TH; Jagla M; LaLone CA; Lagadic L; Lynn SG; Shore B; Song Y; Vliet SM; Wheeler JR; Embry MR
    Environ Toxicol Chem; 2023 Apr; 42(4):757-777. PubMed ID: 36789969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigating endocrine-disrupting properties of chemicals in fish and amphibians: Opportunities to apply the 3Rs.
    Burden N; Embry MR; Hutchinson TH; Lynn SG; Maynard SK; Mitchell CA; Pellizzato F; Sewell F; Thorpe KL; Weltje L; Wheeler JR
    Integr Environ Assess Manag; 2022 Mar; 18(2):442-458. PubMed ID: 34292658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternatives to in vivo tests to detect endocrine disrupting chemicals (EDCs) in fish and amphibians--screening for estrogen, androgen and thyroid hormone disruption.
    Scholz S; Renner P; Belanger SE; Busquet F; Davi R; Demeneix BA; Denny JS; Léonard M; McMaster ME; Villeneuve DL; Embry MR
    Crit Rev Toxicol; 2013 Jan; 43(1):45-72. PubMed ID: 23190036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GOLIATH Project: Towards an Internationally Harmonised Approach for Testing Metabolism Disrupting Compounds.
    Legler J; Zalko D; Jourdan F; Jacobs M; Fromenty B; Balaguer P; Bourguet W; Munic Kos V; Nadal A; Beausoleil C; Cristobal S; Remy S; Ermler S; Margiotta-Casaluci L; Griffin JL; Blumberg B; Chesné C; Hoffmann S; Andersson PL; Kamstra JH
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32423144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethical review of regulatory toxicology guidelines involving experiments on animals: the example of endocrine disrupters.
    Purchase IF
    Toxicol Sci; 1999 Dec; 52(2):141-7. PubMed ID: 10630565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.